SCHEMBL7039587

SCHEMBL7039587

CC(C)n1nc(-c2c(-c3ccccc3)nn3ccccc23)ccc1=O

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.57
IGF1R P08069 2/20 0.49
MAPK1 P28482 5/20 0.46
PDE5A O76074 5/20 0.44
PDE3A Q14432 3/20 0.44
MAPK14 Q16539 2/20 0.43
MAPK3 P27361 1/20 0.43
AKT1 P31749 1/20 0.42
EGFR P00533 2/20 0.41
RAF1 P04049 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
GSK3B P49841 1/20 0.41
PDE4B Q07343 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8193926 0.86 ADORA1 (0.45) ADORA1IGF1RMAPK1PDE5APDE3A
SCHEMBL6822067 0.85 ADORA1 (0.43) ADORA1IGF1RMAPK1MAPK14MAPK3
SCHEMBL6822009 0.85 ADORA1 (0.45) ADORA1IGF1RMAPK1MAPK14MAPK3
SCHEMBL7040213 0.85 ADORA1 (0.42) ADORA1IGF1RMAPK1PDE5APDE3A
SCHEMBL3088123 0.84 ADORA1 (0.59) ADORA1IGF1RMAPK1MAPK14MAPK3
SCHEMBL7040210 0.84 PDE4B (0.42) ADORA1IGF1RMAPK1PDE5APDE3A
SCHEMBL6824772 0.84 ADORA1 (0.44) ADORA1IGF1RMAPK1
SCHEMBL8809138 0.84 ADORA1 (0.64) ADORA1IGF1RMAPK1PDE5APDE3A
SCHEMBL6821959 0.83 ADORA1 (0.42) ADORA1IGF1RMAPK1EGFR
SCHEMBL6818544 0.83 ADORA1 (0.46) ADORA1IGF1RMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232302-B2 Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-31 US disclosed
US-8232302-B2 Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-31 US disclosed
US-20110144123-A1 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-16 US disclosed
US-20110144123-A1 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-16 US disclosed
US-7846951-B2 Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-12-07 US disclosed
US-20090018140-A1 THIAZOLES AND OXAZOLES USEFUL AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2009-01-15 US disclosed
US-7407976-B2 Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-05 US disclosed
WO-2003004494-A1 PYRIDAZINONE COMPOUND AS ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018140-A1 THIAZOLES AND OXAZOLES USEFUL AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 ADORA1 472/4885IGF1R 1973/4885MAPK1 4297/4885
US-20110144123-A1 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 ADORA1 472/4885IGF1R 1973/4885MAPK1 4297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.